Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation

Journal of Immunology

Volumn 189, Issue 8, 2012, Pages 4060-4068

  Hardison, Sarah E ^a   Herrera, Gina ^a   Young, Mattie L ^a   Hole, Camaron R ^a   Wozniak, Karen L ^a   Wormley, Floyd L ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 1; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; FEMALE; FUNGUS GROWTH; GENE EXPRESSION; IMMUNITY; IMMUNIZATION; IMMUNOFLUORESCENCE; IN VITRO STUDY; LUNG HOMOGENATE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY CRYPTOCOCCOSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 84867289173     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103455     Document Type: Article

References (37)

1. Park, B. J., K. A. Wannemuehler, B. J. Marston, N. Govender, P. G. Pappas, and T. M. Chiller. 2009. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23: 525-530.
2. Mitchell, T. G., and J. R. Perfect. 1995. Cryptococcosis in the era of AIDS: 100 years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev. 8: 515-548.
3. Martinez, F. O., L. Helming, and S. Gordon. 2009. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27: 451-483.
4. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958-969.
5. Flesch, I. E., G. Schwamberger, and S. H. Kaufmann. 1989. Fungicidal activity of IFN-γ-activated macrophages: extracellular killing of Cryptococcus neoformans. J. Immunol. 142: 3219-3224. (Pubitemid 19129946)
6. Hardison, S. E., S. Ravi, K. L. Wozniak, M. L. Young, M. A. Olszewski, and F. L. Wormley, Jr. 2010. Pulmonary infection with an interferon-gamma- producing Cryptococcus neoformans strain results in classical macrophage activation and protection. Am. J. Pathol. 176: 774-785.
7. Zhang, Y., F. Wang, K. C. Tompkins, A. McNamara, A. V. Jain, B. B. Moore, G. B. Toews, G. B. Huffnagle, and M. A. Olszewski. 2009. Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99. Am. J. Pathol. 175: 2489-2500.
8. Arora, S., Y. Hernandez, J. R. Erb-Downward, R. A. McDonald, G. B. Toews, and G. B. Huffnagle. 2005. Role of IFN-γ in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis. J. Immunol. 174: 6346-6356. (Pubitemid 40663828)
9. Müller, U., W. Stenzel, G. Köhler, C. Werner, T. Polte, G. Hansen, N. Schütze, R. K. Straubinger, M. Blessing, A. N. McKenzie, et al. 2007. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J. Immunol. 179: 5367-5377.
10. Hardison, S. E., K. L. Wozniak, J. K. Kolls, and F. L. Wormley, Jr. 2010. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection. Infect. Immun. 78: 5341-5351.
11. Wormley, F. L., Jr., J. R. Perfect, C. Steele, and G. M. Cox. 2007. Protection against cryptococcosis by using a murine γ interferon-producing Cryptococcus neoformans strain. Infect. Immun. 75: 1453-1462. (Pubitemid 46385839)
12. Wozniak, K. L., S. Ravi, S. Macias, M. L. Young, M. A. Olszewski, C. Steele, and F. L. Wormley. 2009. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. PLoS ONE 4: e6854.
13. Arora, S., M. A. Olszewski, T. M. Tsang, R. A. McDonald, G. B. Toews, and G. B. Huffnagle. 2011. Effect of cytokine interplay on macrophage polarization during chronic pulmonary infection with Cryptococcus neoformans. Infect. Immun. 79: 1915-1926.
14. Alexander, W. S., R. Starr, J. E. Fenner, C. L. Scott, E. Handman, N. S. Sprigg, J. E. Corbin, A. L. Cornish, R. Darwiche, C. M. Owczarek, et al. 1999. SOCS1 is a critical inhibitor of interferon g signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98: 597-608. (Pubitemid 29418951)
15. Bullen, D. V., R. Darwiche, D. Metcalf, E. Handman, and W. S. Alexander. 2001. Neutralization of interferon-γ in neonatal SOCS1-/- mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory disease. Immunology 104: 92-98.
16. Nicholson, S. E., T. A. Willson, A. Farley, R. Starr, J. G. Zhang, M. Baca, W. S. Alexander, D. Metcalf, D. J. Hilton, and N. A. Nicola. 1999. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J. 18: 375-385. (Pubitemid 29041946)
17. Platanias, L. C. 2005. Mechanisms of type-I- and type-II-interferon- mediated signalling. Nat. Rev. Immunol. 5: 375-386. (Pubitemid 40685987)
18. Chang, N. C., S. I. Hung, K. Y. Hwa, I. Kato, J. E. Chen, C. H. Liu, and A. C. Chang. 2001. A macrophage protein, Ym1, transiently expressed during inflammation is a novel mammalian lectin. J. Biol. Chem. 276: 17497-17506.
19. Guo, L., R. S. Johnson, and J. C. Schuh. 2000. Biochemical characterization of endogenously formed eosinophilic crystals in the lungs of mice. J. Biol. Chem. 275: 8032-8037. (Pubitemid 30159715)
20. Loke, P., A. S. MacDonald, A. Robb, R. M. Maizels, and J. E. Allen. 2000. Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact. Eur. J. Immunol. 30: 2669-2678.
21. Raes, G., P. De Baetselier, W. Noël, A. Beschin, F. Brombacher, and G. Hassanzadeh Gh. 2002. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J. Leukoc. Biol. 71: 597-602.
22. Welch, J. S., L. Escoubet-Lozach, D. B. Sykes, K. Liddiard, D. R. Greaves, and C. K. Glass. 2002. TH2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism. J. Biol. Chem. 277: 42821-42829. (Pubitemid 35285658)
23. Allen, J. E., and P. Loke. 2001. Divergent roles for macrophages in lymphatic filariasis. Parasite Immunol. 23: 345-352. (Pubitemid 32848286)
24. Goerdt, S., O. Politz, K. Schledzewski, R. Birk, A. Gratchev, P. Guillot, N. Hakiy, C. D. Klemke, E. Dippel, V. Kodelja, and C. E. Orfanos. 1999. Alternative versus classical activation of macrophages. Pathobiology 67: 222-226. (Pubitemid 30135909)
25. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3: 23-35. (Pubitemid 37328697)
26. Stein, M., S. Keshav, N. Harris, and S. Gordon. 1992. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176: 287-292.
27. Forman, H. J., and M. Torres. 2002. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am. J. Respir. Crit. Care Med. 166: S4-S8. (Pubitemid 36015930)
28. Hesse, M., M. Modolell, A. C. La Flamme, M. Schito, J. M. Fuentes, A. W. Cheever, E. J. Pearce, and T. A. Wynn. 2001. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 167: 6533-6544. (Pubitemid 33081589)
29. Hickman-Davis, J. M., F. C. Fang, C. Nathan, V. L. Shepherd, D. R. Voelker, and J. R. Wright. 2001. Lung surfactant and reactive oxygen-nitrogen species: antimicrobial activity and host-pathogen interactions. Am. J. Physiol. Lung Cell. Mol. Physiol. 281: L517-L523.
30. Hickman-Davis, J. M., P. O'Reilly, I. C. Davis, J. Peti-Peterdi, G. Davis, K. R. Young, R. B. Devlin, and S. Matalon. 2002. Killing of Klebsiella pneumoniae by human alveolar macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 282: L944-L956. (Pubitemid 34654610)
31. Voelz, K., D. A. Lammas, and R. C. May. 2009. Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans. Infect. Immun. 77: 3450-3457.
32. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421.
33. Hiroi, M., and Y. Ohmori. 2003. The transcriptional coactivator CREB-binding protein cooperates with STAT1 and NF-κB for synergistic transcriptional activation of the CXC ligand 9/monokine induced by interferon-γ gene. J. Biol. Chem. 278: 651-660. (Pubitemid 36043619)
34. Han, C., J. Fu, Z. Liu, H. Huang, L. Luo, and Z. Yin. 2010. Dipyrithione inhibits IFN-γ-induced JAK/STAT1 signaling pathway activation and IP-10/CXCL10 expression in RAW264.7 cells. Inflamm. Res. 59: 809-816.
35. Feldmesser, M., A. Mednick, and A. Casadevall. 2002. Antibody-mediated protection in murine Cryptococcus neoformans infection is associated with pleotrophic effects on cytokine and leukocyte responses. Infect. Immun. 70: 1571-1580. (Pubitemid 34163437)
36. Rivera, J., O. Zaragoza, and A. Casadevall. 2005. Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cells. Infect. Immun. 73: 1141-1150. (Pubitemid 40165774)
37. Chen, G. H., R. A. McDonald, J. C. Wells, G. B. Huffnagle, N. W. Lukacs, and G. B. Toews. 2005. The γ interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans. Infect. Immun. 73: 1788-1796.